1) Hahn, A. et al. Ernährung: Physiologische Grundlagen, Prävention, Therapie, 3. neu bearbeitete und erweiterte Auflage. Stuttgart: Wissenschaftliche Verlagsgesellschaft Stuttgart, 2016.
2) Caruso, F. et al. 2004. Structural basis for antioxidant activity of trans-resveratrol: ab initio calculations and crystal and molecular structure. J Agric Food Chem. 52(24):7279-85.
3) Bagchi, D., et al. 2002. Cellular protection with proanthocyanidins derived from grape seeds. Ann N Y Acad Sci. 957:260-70.
4) De Gaetano, G., Cerletti, C. 2001. European project: FAIR CT 97 3261: Wine and cardiovascular disease. Nutr Metab Cardiovasc Dis. 11(4S):47-50.
5) Lekakis, J. et al. 2005. Polyphenolic compounds from red grapes acutely improve endothelial function in patients with coronary heart disease. Eur J Cardiovasc Prev Rehabil. 12(6):596-600.
6) Bagchi, D. et al. 2003. Molecular mechanism of cardioprotection by a novel grape seed proanthocyanidin extract. Mutat Res. 523-524:87-97.
7) Penumathsa, S. V. et al. 2006. Statin and resveratrol in combination induces cardioprotection against myocardial infarction in hypercholesterolemic rat. J Mol Cell Cardiol. 42(3):508-516. doi: 10.1016/j.yjmcc.2006.10.018.
8) Yoshida, Y. et al. 2007. Resveratrol ameliorates experimental autoimmune myocarditis. Circ J. 71(3):397-404. doi: 10.1253/circj.71.397.
9) Zhang, X. Y. et al. 2005. Proanthocyanidin from grape seeds potentiates anti-tumor activity of doxorubicin via immunomodulatory mechanism. Int Immunopharmacol. 5(7-8):1247-57.
10) Kim, H. et al. 2006. Proteomics analysis of the actions of grape seed extract in rat brain: technological and biological implications for the study of the actions of psychoactive compounds. Life Sci. 78(18):2060-5. doi: 10.1016/j.lfs.2005.12.008.
11) Mokni, M. et al. 2007. Effect of resveratrol on antioxidant enzyme activites in the brain of healthy rat. Neurochem Res. 32(6):981-987. doi: 10.1007/s11064-006-9255-z.
12) Kumar, A. et al. 2007. Effects of resveratrol on nerve functions, oxidative stress and DNA fragmentation in experimental diabetic neuropathy. Life Sci. 80(13):1236-44. doi: 10.1016/j.lfs.2006.12.036.
13) Costantini, A. et al. 1999. Clinical and capillaroscopic evaluation of chronic uncomplicated venous insufficiency with procyanidins extracted from vitis vinifera. Minerva Cardioangiol. 47(1-2):39-46.
14) Watzl, B., Leitzmann, C. Bioaktive Substanzen in Lebensmitteln, 1. Auflage. Stuttgart: Hippokrates Verlag, 1999.
15) Baliga, M. S., Katiyar, S. K. 2006. Chemoprevention of photocarcinogenesis by selected dietary botanicals. Photochem Photobiol Sci. 5:243-53. doi: 10.1039/B505311K.
16) Han, B. et al. 2003. Proanthocyanidin: a natural crosslinking reagent for stabilizing collagen matrices. J Biomed Mater Res A. 65(1):118-24.
17 Li, Y. et al. 2006. Resveratrol- induced cell inhibition of growth and apoptosis in MCF7 human breast cancer cells are associated with modulation of phosphorylated Akt and caspase-9. Appl Biochem Biotechnol. 135(3):181-92. doi: 10.1385/ABAB:135:3:181.
18) Scarlatti, F. et al. 2007. Resveratrol sensitization of DU145 prostate cancer cells to ionizing radiation is associated to ceramide increase. Canc Lett. 253(1):124-130. doi: 10.1016/j.canlet.2007.01.014.
Referenzen Interaktionen
Stargrove, M. B. et al. Herb, Nutrient and Drug Interactions: Clinical Implications and Therapeutic Strategies, 1. Auflage. St. Louis, Missouri: Elsevier Health Sciences, 2008.
Gröber, U. Mikronährstoffe: Metabolic Tuning –Prävention –Therapie, 3. Auflage. Stuttgart: WVG Wissenschaftliche Verlagsgesellschaft Stuttgart, 2011.
Gröber, U. Arzneimittel und Mikronährstoffe: Medikationsorientierte Supplementierung, 3. aktualisierte und erweiterte Auflage. Stuttgart: WVG Wissenschaftliche Verlagsgesellschaft Stuttgart, 2014.
|